Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125526831 | 12552683 | 1 | I | 20151001 | 20160713 | 20160713 | EXP | CA-PFIZER INC-3031908 | PFIZER | 0.00 | M | Y | 0.00000 | 20160713 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125526831 | 12552683 | 1 | PS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Unknown | UNK | U | UNK | 71849 | SOLUTION FOR INJECTION | |||||||
| 125526831 | 12552683 | 2 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 125526831 | 12552683 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, FREQ: 2 DAY; INTERVAL: 1 | U | 0 | 15 | MG | TABLET | ||||||
| 125526831 | 12552683 | 4 | SS | TORADOL | KETOROLAC TROMETHAMINE | 1 | Unknown | UNK | U | UNK | 0 | ||||||||
| 125526831 | 12552683 | 5 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | UNK | 0 | ||||||||||
| 125526831 | 12552683 | 6 | C | FENTANYL. | FENTANYL | 1 | Unknown | UNK | 0 | ||||||||||
| 125526831 | 12552683 | 7 | C | OMEPRAZOL /00661201/ | OMEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 125526831 | 12552683 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | 0 | ||||||||||
| 125526831 | 12552683 | 9 | C | ROSUVASTATIN CALCIUM. | ROSUVASTATIN CALCIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125526831 | 12552683 | 1 | Intervertebral disc protrusion |
| 125526831 | 12552683 | 2 | Intervertebral disc protrusion |
| 125526831 | 12552683 | 3 | Myelofibrosis |
| 125526831 | 12552683 | 4 | Intervertebral disc protrusion |
| 125526831 | 12552683 | 5 | Product used for unknown indication |
| 125526831 | 12552683 | 6 | Product used for unknown indication |
| 125526831 | 12552683 | 7 | Product used for unknown indication |
| 125526831 | 12552683 | 8 | Product used for unknown indication |
| 125526831 | 12552683 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125526831 | 12552683 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125526831 | 12552683 | Abdominal discomfort | |
| 125526831 | 12552683 | Dyspnoea | |
| 125526831 | 12552683 | Intervertebral disc protrusion | |
| 125526831 | 12552683 | Joint swelling | |
| 125526831 | 12552683 | Oedema peripheral | |
| 125526831 | 12552683 | Weight decreased | |
| 125526831 | 12552683 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |